Загрузка...
PPARγ Inhibitors as Novel Tubulin-Targeting Agents
The microtubule-targeting agents (MTAs) are a very successful class of cancer drugs with therapeutic benefits in both hematopoietic and solid tumors. However, resistance to these drugs is a significant problem. Current MTAs bind to microtubules, and/or to their constituent tubulin heterodimers, and...
Сохранить в:
| Главный автор: | |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Hindawi Publishing Corporation
2008
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2396401/ https://ncbi.nlm.nih.gov/pubmed/18509498 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2008/785405 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|